Fuso Chemical (4368) Q3 2025 earnings summary

Executive summary

• Net sales for the nine months ended December 31, 2024, rose 21.5% year-over-year to ¥52,420 million, with operating profit up 53.1% to ¥12,595 million and profit attributable to owners of parent up 50.2% to ¥9,169 million.

• Comprehensive income increased 47.6% year-over-year to ¥9,892 million for the nine-month period.

Financial highlights

• Operating profit before depreciation and amortization reached ¥18,250 million, up from ¥13,160 million year-over-year.

• Earnings per share for the nine months was ¥260.10, compared to ¥173.25 in the prior year period.

• Gross profit for the nine months was ¥19,977 million, up from ¥15,333 million year-over-year.

• Total assets as of December 31, 2024, were ¥135,224 million, with net assets at ¥102,542 million and an equity ratio of 75.8%.

Outlook and guidance

• Full-year forecast for the year ending March 31, 2025, projects net sales of ¥68,000 million (up 15.3% year-over-year), operating profit of ¥13,500 million (up 21.8%), and profit attributable to owners of parent of ¥9,150 million (up 9.7%).

• Full-year EPS is forecast at ¥259.57.

• No revisions to the previously announced financial results or dividend forecasts.